Matt's Profile

Matt is a Shareholder in the Intellectual Property & Technology and Corporate practice groups at Maynard. He advises clients on a wide range of complex transactions involving intellectual property and technology, including technology licensing, strategic collaborations, mergers and acquisitions, joint ventures, supply and distribution arrangements, and other strategic commercial agreements. Matt’s practice focuses on advising both established and emerging companies in a variety of technology-intensive sectors, including biotechnology, pharmaceuticals, software, SaaS, healthcare, consumer electronics, gaming, social media, e-commerce, and other online business models.

As a complement to his transactional IP practice, Matt also assists his clients with day-to-day commercial and corporate matters as well as the preparation and prosecution of patent applications, particularly in the life sciences. Matt also provides guidance on integrating advice from other legal experts, such as litigators and regulatory advisors, so that it aligns with companies’ corporate strategy and practices.

Matt earned his Ph.D. in Biomedical Sciences with a concentration in immunology. He also completed research in the fields of immunology, translational medicine, molecular biology and analytical chemistry, which serves as the backbone to his understanding of the variety of complex scientific and technical matters required when working on behalf of his clients to protect their intellectual property.

Matt's Accolades

  • Best Lawyers: Ones to Watch for Corporate Law, Intellectual Property Law (2021-present)

Matt's Affiliations and Civic Involvement

Affiliations
  • Alabama Bar Association (Intellectual Property, Entertainment, & Sports Law Section)
  • BioAlabama
  • Fly Quest

Admissions

State Bar: Alabama

U.S. District Court: Alabama (Northern)

U.S. Patent & Trademark Office

Education
  • Emory University School of Law
    • (2013, J.D., TI:GER (joint technology commercialization program with Georgia Tech); Emory International Law Review, Symposium Editor; IP Society, Executive Board)
  • University of Florida, College of Medicine
    • (2008, Ph.D., Biomedical Sciences w/concentration in Immunology; Alumni Fellowship)
  • University of Florida
    • (2003, B.S., Microbiology & Cell Science; National Merit Scholar, Honors Program; University Scholars Program)

Monday, August 22, 2022

200 Maynard Attorneys Recognized in The Best Lawyers in America© 2023

Maynard is pleased to announce that 200 of the Firm’s attorneys have been recognized in the 2023 edition of The Best Lawyers in America©, including 11 who are distinguished as “Lawyer of the Year” in their respective areas of expertise and 56 of the Firm’s younger attorneys who are recognized...

Read More
Thursday, August 19, 2021

179 Maynard Attorneys Recognized in The Best Lawyers in America© 2022

Maynard & Gale is pleased to announce that 179 of the Firm’s attorneys have been recognized in the 2022 edition of The Best Lawyers in America©, including 17 who are distinguished as “Lawyer of the Year” in their respective areas of expertise and 48 of the Firm’s younger attorneys who...

Read More
Wednesday, January 6, 2021

Maynard Elevates Nine Attorneys Across National Footprint

BIRMINGHAM, Ala. (January 6, 2021) — Maynard & Gale (Maynard) is pleased to announce the promotion of nine attorneys, effective January 1, 2021: Bo Bledsoe, Ashlee Riopka Elrod, Brandi Maiorino, Virginia McKibbens, Matt Parker, Stephen Rogers, Allie Tucker, and Lindsay Whitworth were promoted as shareholders, and Cindy Mekari Rucker was...

Read More